Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Recombinant Human CD147 Protein (Fc Tag) (AC1002)
Cat.#: ACPP-1002
Specifications
Despition Recombinant Human CD147 Protein (Fc Tag) for SDS-PAGE SIZE 50 µg Source Recombinant Protein Length Fragment Expression System HEK293 cells Protein Species Human Sequence CD147 (Gly140-Ala323) + hFc (Glu99-Ala330) Molecular Weight 46.3 kDa without signal peptide Purity > 95% by SDS-PAGE and Coomassie blue staining. Form Lyophilized Tag C-terminal Human Fc Tag Applications SDS-PAGE Storage Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1180 Native Human Luteinizing Hormone (Functional) (AC1180) 100 µg inquiry ACPP-1197 Dopamine Transporter Blocking Peptide (AC1197) 250 µg inquiry ACPP-1009 Recombinant Human TYRO3 Protein (6×His Tag) (AC1009) 50 µg inquiry ACPP-1114 Recombinant Human NCAM1 Protein (6×His Tag) (AC1114) 50 µg inquiry ACPP-1508 Human I TAC Protein (AC1508) 5 µg inquiry ACPP-1020 Recombinant Human Neurotensin Protein (Fc Tag) (AC1020) 50 µg inquiry ACPP-1313 Norepinephrine Transporter Blocking Peptide (AC1313) 250 µg inquiry ACPP-1455 Human PIN1 Protein (AC1455) 5 µg inquiry ACPP-1401 Rat Midkine Protein (AC1401) 5 µg inquiry ACPP-1147 Recombinant Human NRP2 Protein (6×His Tag) (AC1147) 50 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket